Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Yumanity Therapeutics signs drug development deal with Merck

pharmaceutical-technologyJune 28, 2020

Tag: Yumanity Therapeutics , Merck , neurodegenerative disease , ALS , FTLD

PharmaSources Customer Service